secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2023-03-01T23:59:59+00:00
Accession:  0001558370-23-002475
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne invests $257M for 20% of Wilson Wolf; future buyout up to $1B
------------------------------------------------------------------------

- Wilson Wolf met trailing 12-month EBITDA target of $55M, triggering Bio-Techne's option.
- Bio-Techne will pay $257M for a 20% ownership stake; close expected end of March 2023.
- Remaining 80% can be acquired for $1B if Wilson Wolf hits $226M revenue or $136M EBITDA.
- If milestone not met by Dec 31, 2027, Bio-Techne can buy for ~4.4x trailing revenue.
- Wilson Wolf's G-Rex cell production tech is used by over 800 cell and gene therapy entities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000155837023002475/0001558370-23-002475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000155837023002475/tmb-20230228x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-002475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer